医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

EpiFaith® Expanding to U.S. Military Hospitals After a Newly Awarded Agreement by the Defense Logistics Agency

2021年06月29日 PM11:21
このエントリーをはてなブックマークに追加


 

TAIPEI, Taiwan

Flat Medical Co., Ltd., a MedTech company specializing in safety solutions for anesthesia and critical care procedures, has announced that it has been awarded a Distribution and Pricing Agreement (DAPA) by the Defense Logistics Agency for its flagship product EpiFaith®. This agreement ensures the stable price and delivery for a decade.

With the company’s partnership with the prime vendor, Owens and Minor, a leading distributor in the healthcare industry, Flat Medical has acquired the key to open a big door of growth. EpiFaith® will soon be available in all U.S. military hospitals across the globe.

EpiFaith® has been recognized by experts all around the world. Stanford University Hospital published its experience with the use of EpiFaith® for labor analgesia on parturients last month; this paper increased the interest and awareness regarding this product among anesthesiologists in the U.S. and Europe. “The EpiFaith® Syringe reliably detected the epidural space,” said Dr. Edward T. Riley, Professor of Anesthesiology at Stanford University and the senior author of the publication. “We found using the EpiFaith® syringe was often better than using their regular loss-of-resistance syringe,” he added.

Flat Medical is ready for market expansion. Wen-Chuan Lin, the CEO of Amedifact Co., Ltd., a contract manufacturer of EpiFaith®, stated, “As a long-term partner and supplier, the production quality and the capacity are undoubtedly ready for the market.”

“Finally, we can help deliver innovative solutions and perform safe epidural practices with respected physicians in military hospitals together through this agreement,” said Dr. Joseph Luo, CEO of Flat Medical. “It’s our pleasure to supply EpiFaith to the U.S. troops.”

About Flat Medical Co., Ltd.

Flat Medical is a MedTech company focusing on developing safety solutions for clinical procedures. Supported by key opinion leaders and venture capitalists in the United States, Europe, and Asia, the company is commercializing its products at break-neck speed and developing various applications for its innovative EpiFaith®.

About EpiFaith®

The EpiFaith® syringe is a visual indicating syringe for epidural analgesia. Since its launch in 2020, EpiFaith® is helping anesthesiologists perform epidurals in a safer and easier way, preventing accidental CSF leaks, PDPH, and paralysis associated with the procedure, given its safety and physician-centered design.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210629005068/en/

CONTACT

Karl Tsao

karltsao@flatmedical.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Synaffix宣布与普方生物达成价值2.46亿美元的ADC合作
  • Aurion Biotech Announces IOTA Cell Therapy Trial
  • rf IDEAS将在HIMSS21展会上展示与医疗合作伙伴的合作成果
  • rfアイデアズがHIMSS21でヘルスケアパートナーとの協業を紹介
  • Kyowa Kirin Provides Update on Application for Marketing Authorisation of Istradefylline in Europe for the Treatment of ‘OFF’ Episodes in People Living with Parkinson’s